MedTrace Logo

Epidemiology of Thromboembolism Disease: A Cohort Study

NCT00670540 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 8256

Last updated 2012-05-08

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine different risk factors of thromboembolic disease. Different points will be studied

1. do different types of thromboembolic disease (distal Deep Vein Thrombosis (DVT), proximal DVT, Pulmonary Embolism (PE) and DVT, PE without DVT) have the same clinical significance (risk factors and prognosis) ?
2. Is it necessary to obtain a detailed history of thromboembolic disease ?
3. Do older patients have particular risk factors ?
4. Do preventive treatments modify the level of risk factors and the clinical signs of thromboembolic disease ?
5. Do predictive clinical scores have the same performance for both in and outpatients ?
6. Can patients with a potential high level of thromboembolic risk (surgery, pregnancy) but no clinical thromboembolic symptoms, develop a low risk ?
7. The evolution of the disease in patients with negative or positive Venous ThromboEmbolism (VTE) exploratory tests.

Conditions

  • Vascular Diseases
  • Embolism and Thrombosis
  • Phlebitis
  • Venous Insufficiency
  • Pulmonary Embolism

Interventions

OTHER

procedure of Deep Vein Thrombosis (DVT) and PE (Pulmonary Embolism) diagnosis

patients with a clinical suspicion of Venous ThromboEmbolism (VTE = Deep Vein Thrombosis or Pulmonary Embolism) were eligible

Sponsors & Collaborators

  • Sanofi

    collaborator INDUSTRY

  • Ministry of Health, France

    collaborator OTHER_GOV

  • SFMV (Société Française de Médecine Vasculaire)

    collaborator UNKNOWN

  • University Hospital, Grenoble

    lead OTHER

Principal Investigators

  • Jean Luc JB BOSSON, MD · University Hospital, Grenoble

  • Marie Antoinette SEVESTRE, MD · Amiens University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-11-30
Primary Completion
2009-01-31
Completion
2010-02-28

Countries

  • Belgium
  • France
  • Guadeloupe

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00670540 on ClinicalTrials.gov